Prognostic Value of Prelymphodepletion Absolute Lymphocyte Counts in Relapsed/Refractory DLBCL Patients Treated With CAR-T Cells

Prognostic Value of Prelymphodepletion Absolute Lymphocyte Counts in Relapsed/Refractory DLBCL Patients Treated With CAR-T Cells

Here, study authors investigated the impact of pre-lymphodepletion absolute lymphocyte count on CAR-T cell therapy outcomes. Results demonstrated that pre-LD ALC may serve as a helpful indicator to predict the outcomes of CAR-T cell therapy in patients with R/R DLBCL.

 

Access the full article to read more here.

Read more here: Source link